{"transactions":[{"id":748059,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:05:13.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":19676,"derivative":{"exercise_price":29.55,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":19676},"source":{"system":"sec-edgar","filing":"0001193125-26-259529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312526259529/ownership.xml","form_type":"4"}},{"id":758376,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2026-05-29T20:30:04.000Z","date":"2026-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":4194,"price":8.59,"value":36026.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 27, 2026, to satisfy tax withholding obligations that arose in connection with the vesting of a restricted stock unit award for 16,634 shares that vested in full on May 27, 2026."}],"balance_after":66741,"source":{"system":"sec-edgar","filing":"0001193125-26-248427","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000119312526248427/ownership.xml","form_type":"4"}},{"id":939052,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-14T22:00:10.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to the option shall vest on January 12, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":185000,"derivative":{"exercise_price":8.23,"expiration_date":"2036-01-11","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001193125-26-013021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000119312526013021/ownership.xml","form_type":"4"}},{"id":939051,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2026-01-14T22:00:10.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":24301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a performance restricted stock unit award of common stock, which will vest upon the Issuer's common stock achieving certain specified prices per share."}],"balance_after":70935,"source":{"system":"sec-edgar","filing":"0001193125-26-013021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000119312526013021/ownership.xml","form_type":"4"}},{"id":939050,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairperson"}}],"security":"Common Stock","published_at":"2026-01-14T22:00:10.000Z","date":"2026-01-12","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock, 1/4th of the shares subject to which shall vest on January 12, 2027, and 1/4th of the shares subject to the restricted stock unit award shall vest following each one-year period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":46634,"source":{"system":"sec-edgar","filing":"0001193125-26-013021","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000119312526013021/ownership.xml","form_type":"4"}},{"id":1119721,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:05:26.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":33662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":33662,"derivative":{"exercise_price":17.15,"expiration_date":"2025-06-04","underlying":"Common Stock","underlying_shares":33662},"source":{"system":"sec-edgar","filing":"0000950170-25-083054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017025083054/ownership.xml","form_type":"4"}},{"id":1127176,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T22:40:12.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":65351,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":65351,"derivative":{"exercise_price":2.63,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":65351},"source":{"system":"sec-edgar","filing":"0000950170-25-080459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000095017025080459/ownership.xml","form_type":"4"}},{"id":1127175,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T22:40:12.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":16634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":16634,"source":{"system":"sec-edgar","filing":"0000950170-25-080459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000095017025080459/ownership.xml","form_type":"4"}},{"id":1258525,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-19T22:55:53.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":38679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall be fully vested and exercisable on October 30, 2025, subject to the Reporting Person's continuous service to the Issuer as an advisor on and through the vesting date, inclusive."}],"balance_after":38679,"derivative":{"exercise_price":3.03,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":38679},"source":{"system":"sec-edgar","filing":"0000950170-25-023428","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000095017025023428/ownership.xml","form_type":"4"}},{"id":1403135,"issuer":{"id":5452,"kind":"organization","name":"Kyverna Therapeutics, Inc."},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-19T01:16:28.000Z","date":"2024-09-16","kind":"grant","planned":false,"acquired":true,"shares":66592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option shall vest on each monthly anniversary, such that 100% of the shares subject to the option shall be fully vested and exercisable on the third anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":66592,"derivative":{"exercise_price":6.89,"expiration_date":"2034-09-16","underlying":"Common Stock","underlying_shares":66592},"source":{"system":"sec-edgar","filing":"0000950170-24-107967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000095017024107967/ownership.xml","form_type":"4"}},{"id":1486917,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:48:07.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":23114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of the first anniversary of the date of grant and immediately prior to the date of the next year's annual meeting of stockholders, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date."}],"balance_after":23114,"derivative":{"exercise_price":24.49,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":23114},"source":{"system":"sec-edgar","filing":"0000950170-24-070793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017024070793/ownership.xml","form_type":"4"}},{"id":1711017,"issuer":{"id":4227,"kind":"organization","name":"Beam Therapeutics Inc.","symbol":"BEAM"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-14T21:15:08.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":39046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to one-third of the shares subject to the option on the first anniversary of the date of grant and in equal monthly installments as to the remainder of the shares for two years thereafter, subject to the Reporting Person's continued service with the Company through each vesting date."}],"balance_after":39046,"derivative":{"exercise_price":28.28,"expiration_date":"2033-12-13","underlying":"Common Stock","underlying_shares":39046},"source":{"system":"sec-edgar","filing":"0000950170-23-070395","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745999/000095017023070395/ownership.xml","form_type":"4"}},{"id":1893002,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T20:44:16.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":9808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 11, 2024."}],"balance_after":36271,"source":{"system":"sec-edgar","filing":"0001722482-23-000113","document":"wf-form4_168418343875934.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000172248223000113/wf-form4_168418343875934.xml","form_type":"4"}},{"id":2269746,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T22:16:53.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":6693,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 12, 2023."}],"balance_after":26463,"source":{"system":"sec-edgar","filing":"0001722482-22-000130","document":"wf-form4_165273939485666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000172248222000130/wf-form4_165273939485666.xml","form_type":"4"}},{"id":2303386,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-05T20:59:49.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":1215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 11, 2022."}],"balance_after":19770,"source":{"system":"sec-edgar","filing":"0001722482-22-000087","document":"wf-form4_164919237101467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000172248222000087/wf-form4_164919237101467.xml","form_type":"4"}},{"id":2825169,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-01T22:36:27.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":7236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on February 25, 2022."}],"balance_after":18555,"source":{"system":"sec-edgar","filing":"0001722482-21-000096","document":"wf-form4_161463815280490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000172248221000096/wf-form4_161463815280490.xml","form_type":"4"}},{"id":2943946,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T00:16:19.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":14286,"price":26.68,"value":381150.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported herein reflects the transfer of shares received upon the vesting of restricted stock units. The shares transferred were subject to a lock-up agreement entered into by the Reporting Person on November 5, 2020, in connection with a secondary offering. This transaction was permitted pursuant to an exception in the lock-up agreement for parties that did not participate in such secondary offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions ranging from $26.60 to $26.73, inclusive.  The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above."}],"balance_after":11319,"source":{"system":"sec-edgar","filing":"0001722482-20-000176","document":"wf-form4_160807776567001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000172248220000176/wf-form4_160807776567001.xml","form_type":"4"}},{"id":3248152,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T22:54:09.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":11319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on February 21, 2021."}],"balance_after":25605,"source":{"system":"sec-edgar","filing":"0001722482-20-000063","document":"wf-form4_158267123298865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000172248220000063/wf-form4_158267123298865.xml","form_type":"4"}},{"id":3512969,"issuer":{"id":3546,"kind":"organization","name":"Avantor, Inc.","symbol":"AVTR"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-23T23:26:15.000Z","date":"2019-05-21","kind":"grant","acquired":true,"shares":14286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units that vests on May 21, 2020."}],"balance_after":14286,"source":{"system":"sec-edgar","filing":"0000899243-19-014597","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1702473/000089924319014597/doc4.xml","form_type":"4"}},{"id":116745,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2019-05-16T20:44:23.000Z","date":"2019-05-03","kind":"sale","acquired":false,"shares":7077,"price":117.08,"value":828575.16,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment is being filed solely to gain access to the filing system in order to attach the power of attorney authorization. This line item is being re-reported for this purpose."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0000059478-19-000189","document":"wf-form4a_155803944803676.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000189/wf-form4a_155803944803676.xml","form_type":"4/A","original_submission_date":"2019-05-07"}},{"id":116948,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2019-05-07T18:18:06.000Z","date":"2019-05-03","kind":"sale","acquired":false,"shares":500,"price":117.99,"value":58995.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $117.82 to $118.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000059478-19-000183","document":"wf-form4_155725307162586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000183/wf-form4_155725307162586.xml","form_type":"4"}},{"id":116947,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2019-05-07T18:18:06.000Z","date":"2019-05-03","kind":"sale","acquired":false,"shares":7077,"price":117.08,"value":828575.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $116.68 to $117.46. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0000059478-19-000183","document":"wf-form4_155725307162586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000183/wf-form4_155725307162586.xml","form_type":"4"}},{"id":117106,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Restricted Stock Unit","published_at":"2019-05-03T20:04:04.000Z","date":"2019-05-01","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in two equal installments on May 1, 2018 and May 1, 2019."}],"balance_after":0,"derivative":{"expiration_date":"2019-05-01","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0000059478-19-000181","document":"wf-form4_155691382911366.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000181/wf-form4_155691382911366.xml","form_type":"4"}},{"id":117105,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2019-05-03T20:04:04.000Z","date":"2019-05-01","kind":"tax_withholding","acquired":false,"shares":6173,"price":117.04,"value":722487.92,"ownership":{"direct":true},"balance_after":7577,"source":{"system":"sec-edgar","filing":"0000059478-19-000181","document":"wf-form4_155691382911366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000181/wf-form4_155691382911366.xml","form_type":"4"}},{"id":117104,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2019-05-03T20:04:04.000Z","date":"2019-05-01","kind":"exercise","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13750,"source":{"system":"sec-edgar","filing":"0000059478-19-000181","document":"wf-form4_155691382911366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947819000181/wf-form4_155691382911366.xml","form_type":"4"}},{"id":128245,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2018-06-01T20:16:41.000Z","date":"2018-05-29","kind":"sale","acquired":false,"shares":8426,"price":82.1,"value":691774.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amendment is being filed to add footnotes to the transaction."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 26, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This amendment is being filed to add footnotes to the transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $81.73 to $82.10. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000059478-18-000161","document":"wf-form4a_152788418794578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000161/wf-form4a_152788418794578.xml","form_type":"4/A","original_submission_date":"2018-05-31"}},{"id":128276,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2018-05-31T17:05:37.000Z","date":"2018-05-29","kind":"sale","acquired":false,"shares":8426,"price":82.1,"value":691774.6,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000059478-18-000159","document":"wf-form4_152778632353976.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000159/wf-form4_152778632353976.xml","form_type":"4"}},{"id":129296,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Restricted Stock Unit","published_at":"2018-05-03T20:29:42.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019."}],"balance_after":13750,"derivative":{"underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0000059478-18-000140","document":"wf-form4_152537932835597.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000140/wf-form4_152537932835597.xml","form_type":"4"}},{"id":129295,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2018-05-03T20:29:42.000Z","date":"2018-05-01","kind":"tax_withholding","acquired":false,"shares":5324,"price":81.07,"value":431616.68,"ownership":{"direct":true},"balance_after":8426,"source":{"system":"sec-edgar","filing":"0000059478-18-000140","document":"wf-form4_152537932835597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000140/wf-form4_152537932835597.xml","form_type":"4"}},{"id":129294,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Common Stock","published_at":"2018-05-03T20:29:42.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":13750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13750,"source":{"system":"sec-edgar","filing":"0000059478-18-000140","document":"wf-form4_152537932835597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947818000140/wf-form4_152537932835597.xml","form_type":"4"}},{"id":140844,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":11980,"kind":"person","name":"Shaw Christi","position":1,"cik":"0001702473","reported_name":"Shaw Christi","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and Pres., Lilly Bio-Meds"}}],"security":"Restricted Stock Unit","published_at":"2017-05-08T19:53:24.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019."}],"balance_after":27500,"derivative":{"underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0000059478-17-000146","document":"wf-form4_149427319028934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000146/wf-form4_149427319028934.xml","form_type":"4"}}]}